163 related articles for article (PubMed ID: 8736807)
1. Central glucagon-like peptide-I in the control of feeding.
Gunn I; O'Shea D; Turton MD; Beak SA; Bloom SR
Biochem Soc Trans; 1996 May; 24(2):581-4. PubMed ID: 8736807
[No Abstract] [Full Text] [Related]
2. The glucagon-like peptides: a double-edged therapeutic sword?
Perry T; Greig NH
Trends Pharmacol Sci; 2003 Jul; 24(7):377-83. PubMed ID: 12871671
[No Abstract] [Full Text] [Related]
3. [Glucagon-like peptide-1 (GLP-1) receptor].
Taminato T
Nihon Rinsho; 2002 Jul; 60 Suppl 7():535-41. PubMed ID: 12238094
[No Abstract] [Full Text] [Related]
4. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ
Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
[TBL] [Abstract][Full Text] [Related]
5. The metabolic role of GIP: physiology and pathology.
Morgan LM
Biochem Soc Trans; 1996 May; 24(2):585-91. PubMed ID: 8736808
[No Abstract] [Full Text] [Related]
6. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
7. GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor.
Yang H; Egan JM; Wang Y; Moyes CD; Roth J; Montrose MH; Montrose-Rafizadeh C
Am J Physiol; 1998 Sep; 275(3):C675-83. PubMed ID: 9730951
[TBL] [Abstract][Full Text] [Related]
8. Glucagon, glucagon-like peptide-1 and their receptors: an introduction.
Holst JJ
Acta Physiol Scand; 1996 Jul; 157(3):309-15. PubMed ID: 8830884
[No Abstract] [Full Text] [Related]
9. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
Kolligs F; Fehmann HC; Göke R; Göke B
Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
[TBL] [Abstract][Full Text] [Related]
10. The human glucagon-like peptide-1 (GLP-1) receptor. Cloning and functional expression.
Dillon JS; Wheeler MB; Leng XH; Ligon BB; Boyd AE
Adv Exp Med Biol; 1997; 426():113-9. PubMed ID: 9544263
[No Abstract] [Full Text] [Related]
11. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites.
Yamamoto H; Kishi T; Lee CE; Choi BJ; Fang H; Hollenberg AN; Drucker DJ; Elmquist JK
J Neurosci; 2003 Apr; 23(7):2939-46. PubMed ID: 12684481
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1. Gastrointestinal function and possible mechanism of action.
Wettergren A
Dan Med Bull; 2001 Feb; 48(1):19-28. PubMed ID: 11258148
[No Abstract] [Full Text] [Related]
13. Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats.
Gülpinar MA; Bozkurt A; Coşkun T; Ulusoy NB; Yegen BC
Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G924-9. PubMed ID: 10859222
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 modulates neuronal activity in the rat's hippocampus.
Oka JI; Goto N; Kameyama T
Neuroreport; 1999 Jun; 10(8):1643-6. PubMed ID: 10501550
[TBL] [Abstract][Full Text] [Related]
15. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1, satiety and appetite control.
Blundell JE; Naslund E
Br J Nutr; 1999 Apr; 81(4):259-60. PubMed ID: 10999011
[No Abstract] [Full Text] [Related]
17. Hindbrain contributions to anorexia.
Rinaman L
Am J Physiol Regul Integr Comp Physiol; 2004 Nov; 287(5):R1035-6. PubMed ID: 15475502
[No Abstract] [Full Text] [Related]
18. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
Drucker DJ
Mol Endocrinol; 2003 Feb; 17(2):161-71. PubMed ID: 12554744
[TBL] [Abstract][Full Text] [Related]
19. beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1.
Li Y; Cao X; Li LX; Brubaker PL; Edlund H; Drucker DJ
Diabetes; 2005 Feb; 54(2):482-91. PubMed ID: 15677506
[TBL] [Abstract][Full Text] [Related]
20. Endogenous GLP-1 is involved in beta-amyloid protein-induced memory impairment and hippocampal neuronal death in rats.
Oka J; Suzuki E; Kondo Y
Brain Res; 2000 Sep; 878(1-2):194-8. PubMed ID: 10996151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
